2006Zhongguo linchuang yaolixue yu zhiliaoxueRequires access

Meta-analysis of effectiveness of fluoxetine in treatment of post-stroke depression

Jiang Ya-bin

Open publisher page 0 citations

Abstract

AIM: To further investigate the effectiveness and safety of fluoxetine in treatment of post-stroke depression(PSD).METHODS: The effectiveness and safety of fluoxetine in treatment of PSD patients in 13 controlled studies were analyzed by meta-analysis again in order to assess the comprehensively significant differences and effect size(ES).RESULTS:(1)The scores of Hamilton,and degrees of neurological functional defect and Barthel index in PSD patients before and after treatment with fluoxetine had significant difference(P(0.0005)),and ES: dmean(0.8).(2)Improving degrees of depression symptom,neurological functional defect and activity of daily living scale(ADL) between fluoxetine treatment group and control group had significant difference(P(0.0005)),and ES: dmean(0.8).CONCLUSION: Fluoxetine can significantly ameliorate the depression symptom,neurological functional defect and ADL of patients with PSD,and it has few side effects.

About this research paper

What this paper is about

AIM: To further investigate the effectiveness and safety of fluoxetine in treatment of post-stroke depression(PSD).METHODS: The effectiveness and safety of fluoxetine in treatment of PSD patients in 13 controlled studies were analyzed by meta-analysis again in order to assess the comprehensively significant differences and effect size(ES).RESULTS:(1)The scores of Hamilton,and degrees of neurological functional defect and Barthel index in PSD patients before and after treatment with fluoxetine had significant difference(P(0.0005)),and ES: dmean(0.8).(2)Improving degrees of depression symptom,neurological functional defect and activity of daily living scale(ADL) between fluoxetine treatment group and control group had significant difference(P(0.0005)),and ES: dmean(0.8).CONCLUSION: Fluoxetine can significantly ameliorate the depression symptom,neurological functional defect and ADL of patients with PSD,and it has few side effects.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To further investigate the effectiveness and safety of fluoxetine in treatment of post-stroke depression(PSD).METHODS: The effectiveness and safety of fluoxetine in treatment of PSD patients in 13 controlled studies were analyzed by meta-analysis again in order to assess the comprehensively significant differences and effect size(ES).RESULTS:(1)The scores of Hamilton,and degrees of neurological functional defect and Barthel index in PSD patients before and after treatment with fluoxetine had significant difference(P(0.0005)),and ES: dmean(0.8).(2)Improving degrees of depression symptom,neurological functional defect and activity of daily living scale(ADL) between fluoxetine treatment group and control group had significant difference(P(0.0005)),and ES: dmean(0.8).CONCLUSION: Fluoxetine can significantly ameliorate the depression symptom,neurological functional defect and ADL of patients with PSD,and it has few side effects.

Key concepts: Fluoxetine, Post-stroke depression, Depression (economics), Barthel index, Activities of daily living, Medicine, Significant difference, Stroke (engine)

Related papers

Back to paper searchBrowse research topicsOriginal source
Meta-analysis of effectiveness of fluoxetine in treatment of post-stroke depression — Research Paper | ScholarLens